ATE269293T1 - 6-fluoro(3.1.0)hexan-derivate - Google Patents

6-fluoro(3.1.0)hexan-derivate

Info

Publication number
ATE269293T1
ATE269293T1 AT99931532T AT99931532T ATE269293T1 AT E269293 T1 ATE269293 T1 AT E269293T1 AT 99931532 T AT99931532 T AT 99931532T AT 99931532 T AT99931532 T AT 99931532T AT E269293 T1 ATE269293 T1 AT E269293T1
Authority
AT
Austria
Prior art keywords
group
cycloalkyl
hydrogen atom
alkoxy group
atom
Prior art date
Application number
AT99931532T
Other languages
English (en)
Inventor
Atsuro Nakazato
Toshihito Kumagai
Toshima-Ku
Kazunari Sakagami
Kazuyuki Tomisawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE269293T1 publication Critical patent/ATE269293T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Fertilizers (AREA)
AT99931532T 1998-08-31 1999-07-26 6-fluoro(3.1.0)hexan-derivate ATE269293T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24634398 1998-08-31
JP8260799 1999-03-25
PCT/JP1999/003984 WO2000012464A1 (en) 1998-08-31 1999-07-26 6-fluorobicyclo[3. 1.0]hexane derivatives

Publications (1)

Publication Number Publication Date
ATE269293T1 true ATE269293T1 (de) 2004-07-15

Family

ID=26423636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931532T ATE269293T1 (de) 1998-08-31 1999-07-26 6-fluoro(3.1.0)hexan-derivate

Country Status (12)

Country Link
US (1) US6333428B1 (de)
EP (1) EP1110943B1 (de)
KR (1) KR100469182B1 (de)
CN (1) CN1247527C (de)
AT (1) ATE269293T1 (de)
AU (1) AU746806B2 (de)
CA (1) CA2341865C (de)
DE (1) DE69918136T2 (de)
DK (1) DK1110943T3 (de)
ES (1) ES2222715T3 (de)
PT (1) PT1110943E (de)
WO (1) WO2000012464A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
AU6785401A (en) 2000-06-28 2002-01-08 Taisho Pharmaceutical Co Ltd Novel dicarboxylic acid derivatives
AU2001267855B2 (en) * 2000-06-28 2005-09-08 Taisho Pharmaceutical Co., Ltd. Intermediate and process for producing fluorinated carboxylic acid derivative from the same
EP1423411A2 (de) * 2001-07-09 2004-06-02 Eli Lilly And Company Prodrug von exzitatorischen aminosäuren
AU2002353845A1 (en) * 2001-11-23 2003-06-10 Eli Lilly And Company Prodrugs of excitatory amino acids
US20050009912A1 (en) * 2001-12-21 2005-01-13 Bueno Melendo Ana Belen Prodrugs of excitatory amino acids
CA2471642C (en) * 2001-12-27 2011-05-24 Taisho Pharmaceutical Co., Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
EP1517915B1 (de) * 2002-06-11 2009-01-21 Eli Lilly And Company Prodrugs von exzitatorischen aminosäuren
WO2004004706A1 (en) * 2002-07-05 2004-01-15 Eli Lilly And Company Prodrugs of excitatory amino acids
CA2530706C (en) 2003-06-26 2012-11-27 Taisho Pharmaceutical Co., Ltd. 2-amino-bicyclo[3.1.0] hexane-2,6-dicarboxylic ester derivative
RU2409557C2 (ru) * 2003-06-26 2011-01-20 Таишо Фармасьютикал Ко., Лтд. Сложноэфирное производное 2-амино-бицикло[3.1.0]гексан-2,6-дикарбоновой кислоты
RU2388747C2 (ru) * 2003-11-07 2010-05-10 Тайсо Фармасьютикал Ко., Лтд. Способы получения производных бицикло [3.1.0]гексана и промежуточные соединения для этой цели
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
EP1928437A2 (de) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (de) * 2006-09-08 2009-06-17 Braincells, Inc. Kombinationen mit einem 4-acylaminopyridin-derivat
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US8252937B2 (en) 2007-09-14 2012-08-28 Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
US8722894B2 (en) * 2007-09-14 2014-05-13 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones
PL2203439T3 (pl) 2007-09-14 2011-06-30 Addex Pharmaceuticals Sa 1',3'-dipodstawione-4-fenylo-3,4,5,6-tetrahydro-2H, 1'H-[1, 4']bipirydynylo-2'-ketony
RU2492170C9 (ru) * 2007-11-14 2013-12-27 Орто-Макнейл-Янссен Фармасьютикалз, Инк. Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
WO2009142184A1 (ja) 2008-05-21 2009-11-26 大正製薬株式会社 酵素を用いたビシクロ[3.1.0]ヘキサン誘導体の製造方法
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
RU2517181C2 (ru) 2008-10-16 2014-05-27 Орто-Макнейл-Янссен Фармасьютикалз, Инк. Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153912A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 1, 2, 4,-triazolo[4,3-a[pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (zh) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
EP2661435B1 (de) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazol[4,3-a]pyridinderivate und ihre verwendung als positive allosterische mglur2-rezeptormodulatoren
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
PT2721012T (pt) 2011-06-17 2016-07-27 Lilly Co Eli Derivados do ácido biciclo(3.1.0)hexano-2,6¿dicarboxílico como agonista do recetor mglu2
AR089718A1 (es) * 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20220049612A (ko) 2014-01-21 2022-04-21 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
HUE053734T2 (hu) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750566A (en) 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
PL182285B1 (pl) 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
IL118727A (en) * 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
GB9605429D0 (en) 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
AU703093B2 (en) * 1995-11-16 1999-03-18 Eli Lilly And Company Excitatory amino acid receptor antagonists
ZA969485B (en) 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP3727791B2 (ja) * 1998-01-08 2005-12-14 ファイザー・プロダクツ・インク 二環式[3.1.0]ヘキサン及び関連化合物
JP4171549B2 (ja) 1998-01-28 2008-10-22 大正製薬株式会社 含フッ素アミノ酸誘導体
ATE236118T1 (de) 1998-01-28 2003-04-15 Taisho Pharmaceutical Co Ltd Fluorhaltige aminosäurederivate

Also Published As

Publication number Publication date
US6333428B1 (en) 2001-12-25
PT1110943E (pt) 2004-08-31
EP1110943B1 (de) 2004-06-16
DK1110943T3 (da) 2004-10-11
CA2341865C (en) 2006-01-17
CN1247527C (zh) 2006-03-29
KR100469182B1 (ko) 2005-02-02
DE69918136D1 (de) 2004-07-22
CA2341865A1 (en) 2000-03-09
EP1110943A1 (de) 2001-06-27
EP1110943A4 (de) 2002-07-10
CN1383423A (zh) 2002-12-04
DE69918136T2 (de) 2005-07-07
AU4800799A (en) 2000-03-21
KR20010092268A (ko) 2001-10-24
AU746806B2 (en) 2002-05-02
ES2222715T3 (es) 2005-02-01
WO2000012464A1 (en) 2000-03-09
HK1049996A1 (en) 2003-06-06

Similar Documents

Publication Publication Date Title
ATE269293T1 (de) 6-fluoro(3.1.0)hexan-derivate
ATE236118T1 (de) Fluorhaltige aminosäurederivate
WO2003051315A3 (en) Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
TW200634016A (en) Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors
SG155938A1 (en) Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
ATE486600T1 (de) Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5
WO2003051833A3 (en) Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
WO2003053922A3 (en) Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
EP1099692A4 (de) N,n-substituierte cyclische aminderivate
NZ590951A (en) Cyclic nucleotide phosphodiesterases PDE10 inhibitors for treating neurological disorders
WO2004089306A3 (en) Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
MXPA05012391A (es) Tratamiento de trastornos psicoticos y depresivos.
BG106228A (en) Substituted imidazothiazoles as antidepressant agents
EP1637517A4 (de) 2-aminobicyclo¬3.1.0|hexan-2,6-dicarbonsäureesterderivat
ATE324369T1 (de) Heterodiazinon-derivate
AU696458B2 (en) Optically active, substituted phenylalkylamine derivatives
ATE361072T1 (de) N-acetyl-l-pipecolic säure als promoter der produktion des neurotrophischen faktors
HUT58339A (en) Process for producing new organosilane derivatives and pharmaceutical compositions containing them
AU2008258664A8 (en) Prolinamide-tetrazole derivatives as NK3 receptor antagonists
DOP2004000983A (es) Antagonistas 4-cicloalquilaminopirazol pirimidina de nmda/nr2b

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1110943

Country of ref document: EP